Septic polyarthritis with Ureaplasma urealyticum in a patient with prolonged agammaglobulinemia and B-cell aplasia after allogeneic HSCT and rituximab pretreatment.
Arber
C
C
Buser
A
A
Heim
D
D
Weisser
M
M
Tyndall
A
A
Tichelli
A
A
Passweg
J
J
Gratwohl
A
A
D000328:Adult; D000361:Agammaglobulinemia / Q000150:complications / Q000276:immunology / Q000473:pathology; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001170:Arthritis, Infectious / Q000150:complications* / Q000276:immunology / Q000382:microbiology; D001402:B-Lymphocytes / Q000473:pathology; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D016393:Lymphoma, B-Cell / Q000188:drug therapy / Q000473:pathology; D008297:Male; D000069283:Rituximab; D016869:Ureaplasma Infections / Q000150:complications* / Q000276:immunology; D016990:Ureaplasma urealyticum
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab